| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 6 Jun 2026 | 28 May 2026 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/06/2026 inter alia to consider and approve Details related to AGM Outcome of Meeting of Board of Directors held on Saturday, June 06, 2026 (As per BSE Announcement dated on: 06.06.2026) | ||
| Board Meeting | 5 Jun 2026 | 5 Jun 2026 |
| Appointment of Ms. Shruti Sharma (M. No.: A52723) as Company Secretary and Compliance Officer of the Company w.e.f. 05th June, 2026. | ||
| Board Meeting | 18 May 2026 | 11 May 2026 |
| A.G.M. Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve AGM | ||
| Board Meeting | 9 May 2026 | 22 Apr 2026 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 ,inter alia, to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March, 2026 along with the Auditors Report. Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 ,inter alia, to consider and approve Audited Results and Audit Report (As per BSE Announcement dated on: 30.04.2026) Audited Financial Results along with Auditors Report for the Quarter and Year ended March 2026 Audited Financial Results for the Quarter and Year ended March 2026 (As Per BSE Annoncement Dated on:09.05.2026) | ||
| Board Meeting | 20 Mar 2026 | 11 Mar 2026 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2026 ,inter alia, to consider and approve Independent Directors Meeting. Board Meeting Outcome for Independent Directors Meeting (As per BSE announcement dated on :20.03.2026) | ||
| Board Meeting | 13 Feb 2026 | 9 Feb 2026 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Unaudited financial result for the Third Quarter ended on 31st December 2025 along with the Auditors Limited Review Report. Un-Audited Financial Results (UFR) for the Third quarter and Nine Months ended December 31, 2025, along with the Statutory Auditors Limited Review Report. (As Per BSE Announcement Dated on 13.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 5 Nov 2025 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 inter alia to consider and approve Unaudited financial result for the half year ended on 30th September 2025 along with the Auditors Limited Review Report. Board meeting of the company adjourned to tomorrow i.e. November 12, 2025 due to unavoidable circumstances. With reference to the above cited subject, this is to inform it was intimated that the meeting of Board of Directors of the Company is scheduled to be held on Tuesday, November 11, 2025, inter-alia to consider and approve Un-audited Financial Results of the Company for the Second quarter and Half year ended on September 30, 2025. This is to intimate that in the Board Meeting held today, the Chairman with the consent of all the directors present at the meeting hereby decided to adjourn the Meeting of Board of Directors due to unavoidable circumstances and decided that the Meeting of Board of Directors will continue to be held on Wednesday, November 12, 2025 inter-alia to consider and approve Un-audited Financial Results of the Company for the Second quarter and Half year ended on September 30, 2025 and any other item with the permission of Chairman. (As per BSE Announcement dated on: 11.11.2025) The Board meeting of the company further adjourned on Thursday November 13, 2025 due to unavoidable circumstances. (As Per BSE Announcement Dated on 12.11.2025) This is to intimate that in the Board Meeting held today, the Chairman with the consent of all the directors present at the meeting hereby decided to further adjourn the Meeting of Board of Directors due to unavoidable circumstances and decided that the Meeting of Board of Directors will continue to be held on Friday, November 14, 2025 inter-alia to consider and approve Un-audited Financial Results of the Company for the Second quarter and Half year ended on September 30, 2025 and any other item with the permission of Chairman (As Per BSE Announcement Dated on 13.11.2025) Outcome Of The Meeting Of The Board Of Directors Held On Friday, November 14, 2025. (As Per BSE Announcement Dated on: 19/11/2025) Revised Financial Result for the quarter ended September 30, 2025. (As per BSE Announcement dated on: 01.12.2025) | ||
| Board Meeting | 13 Aug 2025 | 8 Aug 2025 |
| Natural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 inter alia to consider and approve Unaudited financial result for the first quarter ended on 30th June 2025 along with the Auditors Limited Review Report Un-Audited Financial Results (UFR) for the first quarter ended June 30, 2025, along with the Statutory Auditors Limited Review Report. (As Per BSE Announcement Dated on: 13.08.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
